LLY vs WFC: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Eli Lilly and Company · Healthcare
$1,179.09
+31.7% upside to fair value
High Conviction
Grade A
High Quality
VS
Wells Fargo & Company · Financial Services
$87.53
+18.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
LLY has more upside to fair value
(+31.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
WFC |
| Current Price |
$1,179.09 |
$87.53 |
| Fair Value Estimate |
$1,552.32 |
$103.38 |
| Upside to Fair Value |
+31.7%
|
+18.1%
|
| Market Cap |
$1,110.4B |
$267.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
34.3x
|
15.8x
|
| Price / Sales |
14.6x
|
2.1x
|
| Price / FCF |
77.7x
|
226.4x
|
| Revenue Growth YoY |
+55.5%
|
+11.3%
|
| Gross Margin |
83.5%
|
64.5%
|
| Operating Margin |
45.9%
|
21.2%
|
| Return on Equity |
101.3%
|
12.6%
|
| Dividend Yield |
0.55% |
2.06% |
| FCF Yield |
1.29%
|
0.44%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Eli Lilly is a global biopharma company whose exceptionally profitable cardiometabolic franchises, led by Mounjaro and Zepbound, are driving a high-quality growth phase: revenue rose 55.5% year over year and earnings rose 168.0% year over year in the most recent quarter, while gross, operating, and net margins were 83.5%, 45.9%, and 35.0%, respectively. Business quality is high because tirzepatid…
Wells Fargo is a diversified U.S. bank operating consumer and commercial banking, corporate and investment banking, and wealth management, supported by a large deposit franchise, a $2.3 trillion asset base, nationwide advisory distribution, and increasingly relevant capital-markets capabilities. Business quality is high but not without legacy constraints: return on equity is 12.6%, gross margin i…
Accumulation Zones
| Metric |
LLY |
WFC |
| Zone Low |
$1,164.24 |
$77.53 |
| Zone High |
$1,319.47 |
$87.87 |
| In Buy Zone? |
Yes
|
Yes
|